Cost of Capital and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Cost of Capital

Pharmaceuticals

Should Companies Retain "Strategic" Cash?

Harvard Business Review

APRIL 16, 2012

Strategic cash also can be used to finance long-term reinvestment programs in the business—which is especially valuable to companies in capital-intensive industries (e.g., high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs. energy or telecom) or research-intensive industries (e.g.,

Company

Company Cost of Capital Finance Long-term

What’s Driving Superstar Companies, Industries, and Cities

Harvard Business Review

OCTOBER 25, 2018

To analyze the superstar dynamics of firms, our metric was economic profit, a measure of a firm’s profit above and beyond opportunity cost. (To To do this, we take the firm’s returns, deduct the cost of capital, and multiply by the firm’s total invested capital.)

Industry

Industry Company GDP Bottom-up

Leadership Digital

Should Companies Retain "Strategic" Cash?

What’s Driving Superstar Companies, Industries, and Cities

Stay Connected